Grunenthal USA Inc - Company Review
Grunenthal USA Inc - Company ReviewSummary
Grunenthal USA Inc (Grunenthal USA), a subsidiary of Grunenthal GmbH is a pharmaceutical company that develops drugs for pain management. The company develops formulation drug delivery technology which include INTAC, a tamper resistant formulation. INTAC technology is designed to prevent the abuse or inadvertent misuse from tablet tampering through the imposition of a specific mechanical stability to the tablet. The company also offers exploratory and translational studies in the area of pain and early and late stage clinical development. It partners with other pharmaceutical companies to deliver products. Grunenthal USA is headquartered in Morristown, New Jersey, the US.
This comprehensive company report of Grunenthal USA Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.